Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.

BACKGROUND Improvements in cancer survival have made the long-term risks from treatments more important, including the risk of developing a second cancer after radiotherapy. We aimed to estimate the proportion of second cancers attributable to radiotherapy in adults with data from the US Surveillance, Epidemiology and End Results (SEER) cancer registries. METHODS We used nine of the SEER registries to systematically analyse 15 cancer sites that are routinely treated with radiotherapy (oral and pharynx, salivary gland, rectum, anus, larynx, lung, soft tissue, female breast, cervix, endometrial, prostate, testes, eye and orbit, brain and CNS, and thyroid). The cohort we studied was composed of patients aged 20 years or older who were diagnosed with a first primary invasive solid cancer reported in the SEER registries between Jan 1, 1973, and Dec 31, 2002. Relative risks (RRs) for second cancer in patients treated with radiotherapy versus patients not treated with radiotherapy were estimated with Poisson regression adjusted for age, stage, and other potential confounders. FINDINGS 647,672 cancer patients who were 5-year survivors were followed up for a mean 12 years (SD 4.5, range 5-34); 60,271 (9%) developed a second solid cancer. For each of the first cancer sites the RR of developing a second cancer associated with radiotherapy exceeded 1, and varied from 1.08 (95% CI 0.79-1.46) after cancers of the eye and orbit to 1.43 (1.13-1.84) after cancer of the testes. In general, the RR was highest for organs that typically received greater than 5 Gy, decreased with increasing age at diagnosis, and increased with time since diagnosis. We estimated a total of 3266 (2862-3670) excess second solid cancers that could be related to radiotherapy, that is 8% (7-9) of the total in all radiotherapy patients (≥1 year survivors) and five excess cancers per 1000 patients treated with radiotherapy by 15 years after diagnosis. INTERPRETATION A relatively small proportion of second cancers are related to radiotherapy in adults, suggesting that most are due to other factors, such as lifestyle or genetics. FUNDING US National Cancer Institute.

[1]  P Fraser,et al.  Radiation dose and second cancer risk in patients treated for cancer of the cervix. , 1988, Radiation research.

[2]  R. Hoover,et al.  New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. , 2006 .

[3]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[4]  J. Humm,et al.  Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Bingshu E. Chen,et al.  Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. , 2007, Journal of the National Cancer Institute.

[6]  Kara Hamilton,et al.  Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[7]  J. Boice,et al.  Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. , 2008, International journal of radiation oncology, biology, physics.

[8]  D. Brenner,et al.  Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery , 2000, Cancer.

[9]  D. L. Preston,et al.  Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998 , 2007, Radiation research.

[10]  John D Boice,et al.  Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. , 2005, Journal of the National Cancer Institute.

[11]  M. Stovall,et al.  Lung cancer risk and radiation dose among women treated for breast cancer. , 1994, Journal of the National Cancer Institute.

[12]  B. Emami,et al.  Second primary cancers in patients with laryngeal cancer: a population-based study. , 2003, International journal of radiation oncology, biology, physics.

[13]  J. Tward,et al.  The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. , 2008, The Journal of clinical endocrinology and metabolism.

[14]  Beate Ritz,et al.  Radiotherapy for oral cancer as a risk factor for second primary cancers. , 2005, Cancer letters.

[15]  F. Levi,et al.  Cancer risk after radiotherapy for breast cancer , 2006, British Journal of Cancer.

[16]  J. Coebergh,et al.  Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Kry,et al.  Second solid cancers after radiotherapy for breast cancer in SEER cancer registries , 2010 .

[18]  C. Rubino,et al.  Increased risk of second cancers following breast cancer: Role of the initial treatment , 2000, Breast Cancer Research and Treatment.

[19]  Yan Liu,et al.  A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. , 2003, American journal of epidemiology.

[20]  G. Nicholas,et al.  A Population-Based Analysis of Second Primary Cancers After Irradiation for Rectal Cancer , 2007, American journal of clinical oncology.

[21]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[22]  C. Rubino,et al.  Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment , 2003, British Journal of Cancer.

[23]  Cancer in the contralateral breast after radiotherapy for breast cancer. , 1992, The New England journal of medicine.

[24]  M. Hauptmann,et al.  Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. , 2009, International journal of radiation oncology, biology, physics.

[25]  N. Day,et al.  Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. , 1985, Journal of the National Cancer Institute.

[26]  P. Hall,et al.  Second primary malignancies in thyroid cancer patients , 2003, British Journal of Cancer.

[27]  Lars Påhlman,et al.  Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  E. Hall,et al.  Intensity-modulated radiation therapy, protons, and the risk of second cancers. , 2006, International journal of radiation oncology, biology, physics.

[29]  M. Schlumberger,et al.  131I Effective Half-Life and Dosimetry in Thyroid Cancer Patients , 2008, Journal of Nuclear Medicine.

[30]  C. Rubino,et al.  Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment , 2005, Breast Cancer Research and Treatment.

[31]  E. Ron,et al.  Comparison of Second Cancer Risks from Brachytherapy and External Beam Therapy After Uterine Corpus Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[32]  K. Warnakulasuriya,et al.  Multiple primary tumours following head and neck cancer in southern England during 1961–98 , 2003 .

[33]  C. Edmonds,et al.  The long-term hazards of the treatment of thyroid cancer with radioiodine. , 1986, The British journal of radiology.

[34]  M. Andersson,et al.  Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977–2001 , 2008, Acta oncologica.

[35]  Marilyn Stovall,et al.  Dose Reconstruction for Therapeutic and Diagnostic Radiation Exposures: Use in Epidemiological Studies , 2006, Radiation research.